Catheter Precision, Inc. Announces Pricing of $3.1 Million Underwritten Public Offering

Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based medical device company, has announced the pricing of its underwritten public offering. This offering includes common stock units and pre-funded units, aiming to raise approximately $3.1 million in gross proceeds before underwriting discounts and expenses.

The offering consists of 347,277 common stock units at $1.00 each and 2,773,000 pre-funded warrant units at $0.9999 each. Each unit contains one share of common stock or a pre-funded warrant, plus three warrants to purchase one share each, expiring in six months, eighteen months, and five years respectively. Ladenburg Thalmann & Co. Inc. serves as the sole book-running manager for the transaction.

Catheter Precision has also granted a 45-day option for the underwriter to purchase additional shares to cover over-allotments. The offering is expected to close around September 3, 2024, pending customary conditions.

The securities are being offered following effective registration statements filed with the SEC. A final prospectus will be available through the SEC's website or from Ladenburg Thalmann & Co. Inc. This announcement does not constitute an offer or solicitation in any jurisdiction where such activities would be unlawful prior to registration or qualification under applicable laws.